Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 791. The contact email is not on this page.
- SURGIVANCE, INC.
NIH R44: Advanced Surgical Pathology Device
startup · OR · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NIMBLE SURGICAL INCORPORATED
NIH R43: FlexLock - A novel anchoring guide catheter to simplify transradial complex percutaneous coronary interventions
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BIOINVISION, INC.
NIH R44: TissueReM: Whole-Organism, Real-time Decision-enabled 3D Tissue Imaging and Recovery for Molecular Analysis
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Orbit Genomics, Inc.
Form D history: Biotechnology
startup · CO · amount not stated · 2025-07-28
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-07-28.
- ONVAGUS, INC.
NIH R44: Neuromodulation of the Gut-Brain Axis to Treat Cancer-Associated Cachexia
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NORTHSTAR GENOMICS, LLC
NIH R41: Bioengineering strategies for exogenic organ production
startup · MN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PROACTIVE LIFE, INC.
NIH R43: An Internet of Things Automated Cognitive Behavioral Therapy for Insomnia that Improves Cognition in Older Adults
startup · VA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Double Helix Optics, Inc.
Form D history: Other Technology
startup · CO · amount not stated · 2021-03-10
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2021-03-10.
- ASAKE BIOTECHNOLOGY, LLC
NIH R42: A dual-acting small molecule for the treatment of type 1 diabetes
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- APTUS BIOSCIENCES LLC
NIH R43: Sepsis diagnosis using chemically modified DNA aptamers
startup · FL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Unlocked Labs
Unlocked Labs is a nonprofit organization focused on building a better justice system by employing currently and formerly incarcerated software developers to create technology that makes education more accessible in prisons.
startup · WY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CURI BIO INC
NIH R44: A cross-species preclinical platform to enhance the translation of new medicines
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SERPIN PHARMA, LLC
NIH R44: A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral Neuropathy
startup · VA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ADVENT THERAPEUTICS, INC.
NIH R44: Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CORIDEA, LLC
NIH R44: ENT-based Approach to Cervical Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CELLECTGEN, INC.
NIH R44: DEVELOPMENT OF A SALIVARY ASSAY FOR MEASURING PERIODONTAL DISEASE ACTIVITY
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HIDO TECHNOLOGIES, INC.
NIH R44: Preventing Medication Mismanagement in People Living with Dementia through Automated Medication Dispensing with Facial Recognition and Video Observation
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ASCLEPIA TECHNOLOGY LLC
NIH R43: Development of targeted cellular therapy for atherosclerotic vascular disease in minority patients
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- IKAIKA THERAPEUTICS, INC.
Form D history: Other Health Care
startup · IL · amount not stated · 2021-11-09
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2021-11-09.
- NEUROROBOTIC TECHNOLOGIES, LLC
NIH R42: Development and assessment of a powered prosthetic digit system with novel wrist-based control and integrated sensory feedback
startup · UT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RareCyte, Inc.
Form D history: Other
startup · WA · amount not stated · 2023-07-25
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-07-25.
- CFD RESEARCH CORPORATION
NIH R44: A synergistic in vitro-in silico model of the placental barrier for predicting fetal exposure and toxicity of xenobiotic compounds
startup · AL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Rational Vaccines, Inc.
Form D history: Biotechnology
startup · MA · amount not stated · 2022-06-28
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2022-06-28.
- RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC
NIH R44: Cloud/Subscription based, Customer-Responsive Dosimetry Tool for alpha-Particle Emitters
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AUTONOMOUS HEALTHCARE, INC.
NIH R43: Noncontact Remote Monitoring for the Detection of Opioid-Induced Respiratory Depression
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VAXIION THERAPEUTICS, INC.
NIH R43: Preclinical development of VAX024 - a novel targeted combination STING agonist/oncolytic agent
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CATRX, INC.
NIH R44: JAML is a first-in-class cancer immunotherapy target for tissue-resident memory T cells.
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- APPLIED UNIVERSAL DYNAMICS CORPORATION
NIH R44: Using Structured Light Sensing with Machine Learning to Detect Unwitnessed In-Home Falls
startup · MN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- THINK THERAPEUTICS, INC.
NIH R43: Brilliant epitopes for improved cancer vaccines
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Sonara Health, Inc.
Form D history: Other Health Care
startup · TX · amount not stated · 2025-05-22
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-05-22.
- BEDROCK THERAPEUTICS, INC.
NIH R42: Prevention of corneal transplant rejection using AAV-BDRK-401 therapy
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- IPACES, LLC
NIH R44: Neuro-exergaming for the Prevention and Remediation of Decline due to Parkinson's Disease: Clinical Trial of the Interactive Physical and Cognitive Exercise System (iPACES v3)
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NEXTGENJANE, INC.
NIH R44: Performance evaluation of a non-invasive menstrual test for endometriosis in infertility patients
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- N'WAII INC.
NIH R43: First in Class Mitochondrially targeted antioxidants with transcriptional modulator capabilities and their implication in the diseases of the eye
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Centivax
Centivax’s mission is to accelerate the world’s transition to a post-pathogen humanity. The company is focused on developing broad-spectrum vaccines, including a universal influenza vaccine currently in pre-clinical development.
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MICROBRIGHTFIELD, LLC
NIH R44: Next generation axonal quantification and classification using AI
startup · VT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AYANA BIO LLC
NIH R43: Engineering Saffron Plant Cell Culture to Produce Neuroprotective Bioactives
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EnClear Therapies
EnClear Therapies aims to improve and extend the lives of patients suffering from central nervous system (CNS) disorders through precision dosing using their proprietary EnTrega CSF Platform.
startup · MA · amount not stated · 2024-03-01
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-03-01.
- NEUROAGE THERAPEUTICS INC.
NIH R43: Development of a Novel Kinase Inhibitor Therapeutic for Alzheimer's Disease
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- DEEP CREEK PHARMA, LLC
NIH R42: Improved Treatment of Colorectal Cancer with CF10
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.